Mon - Sat : 10:00 AM - 06:00 PM Plot No. 43, Industrial Area, Phase -2, Panchkula – 134113
+91 8727990700
+91
8727991700
+91
172-2912507
BIOCORP LIFE SCIENCES PVT LTD
Plot No. 43, Industrial Area, Phase -2, Panchkula – 134113
Table of Contents
India is one of the world’s largest producers of generic medicines and a trusted manufacturing hub for antiparasitic formulations. Among these, Albendazole and Ivermectin Tablets are widely manufactured and supplied to hospitals, pharmacies, distributors, exporters, and PCD pharma franchise businesses.
With increasing awareness of parasitic infections, expanding healthcare access, and growing pharmaceutical distribution networks, the demand for Albendazole and Ivermectin tablets continues to remain strong across domestic and international markets.
Albendazole and Ivermectin are antiparasitic medicines commonly combined to provide broad-spectrum activity against various parasitic infections.
| Composition |
|---|
| Albendazole 400 mg + Ivermectin 6 mg |
| Albendazole 400 mg + Ivermectin 12 mg |
These formulations are available in different packaging options, including blister packs, Alu-Alu packs, and customized private-label packaging.
Several factors contribute to the consistent demand for Albendazole and Ivermectin tablets:
For distributors and pharma marketers, this makes the product an important part of a general medicine portfolio.
Before selecting a manufacturing partner, businesses should evaluate:
A reliable manufacturer can help ensure product quality, regulatory compliance, and uninterrupted supply.
India has numerous pharmaceutical companies manufacturing antiparasitic formulations. Some notable names in this segment include:
| Manufacturer | Business Focus |
|---|---|
| Delwis Healthcare | Third-Party Manufacturing |
| Biofield Pharma | WHO-GMP Manufacturing |
| Vibcare Pharma | Pharma Franchise & Distribution |
| BioCorp Lifesciences | Contract Manufacturing & PCD Pharma |
| Hiral Labs | Export-Oriented Manufacturing |
| Trumac Healthcare | PCD Franchise Solutions |
| Sarva Pharmaceuticals | Generic Medicine Manufacturing |
| Fedley Healthcare | Third-Party Manufacturing Services |
Businesses should compare manufacturers based on certifications, product availability, pricing, packaging, and delivery commitments before making a decision.
BioCorp Lifesciences is among the pharmaceutical companies involved in manufacturing and supplying various pharmaceutical formulations. The company serves distributors, pharma marketers, and franchise partners through contract manufacturing and PCD pharma business models.
When evaluating BioCorp Lifesciences or any other manufacturer, buyers should consider factors such as manufacturing standards, product portfolio, supply capabilities, and commercial support.
Albendazole and Ivermectin tablets remain popular in the franchise market because:
As a result, many pharma franchise companies include antiparasitic products as part of their core product range.
Indian manufacturers export Albendazole and Ivermectin tablets to several international markets due to:
This creates opportunities for exporters, distributors, and pharmaceutical marketers looking to expand their business beyond India.
Albendazole and Ivermectin Tablets are among the most commonly traded antiparasitic formulations in India’s pharmaceutical market. Pricing varies based on composition strength, manufacturing quality, packaging type, and order quantity. For distributors, PCD pharma companies, and exporters, understanding market pricing trends helps in evaluating supplier competitiveness and profit margins.
| Product Strength | Approximate B2B Price (Per Strip) |
|---|---|
| Albendazole 400 mg + Ivermectin 6 mg | ₹35 – ₹65 |
| Albendazole 400 mg + Ivermectin 12 mg | ₹45 – ₹90 |
| Premium Export Packaging | ₹70 – ₹120 |
| Private Label Manufacturing | Depends on MOQ & Packaging |
| Factor | Impact on Price |
|---|---|
| API (Raw Material) Cost | High |
| WHO-GMP Manufacturing Standards | Moderate to High |
| Alu-Alu Packaging | Increases Cost |
| Bulk Order Quantity | Reduces Cost |
| Custom Branding | Increases Cost |
| Export Documentation | Increases Cost |
| Freight & Logistics | Variable |
| Cost Component | Share of Final Product Cost |
|---|---|
| Active Ingredients (Albendazole & Ivermectin) | 35-45% |
| Manufacturing & Quality Control | 20-25% |
| Packaging Material | 10-15% |
| Regulatory & Compliance Costs | 5-10% |
| Logistics & Distribution | 10-15% |
| Marketing & Business Support | 5-10% |
| Business Model | Typical Pricing Advantage |
|---|---|
| Direct Manufacturer Purchase | Lowest Cost |
| Third-Party Manufacturing | Better Brand Ownership |
| PCD Pharma Franchise | Moderate Investment |
| Distributor Procurement | Volume-Based Discounts |
| Export Procurement | Higher Packaging Cost |
| Order Volume | Expected Cost Benefit |
|---|---|
| 5,000–10,000 Strips | Standard Pricing |
| 10,000–25,000 Strips | 5-10% Savings |
| 25,000–50,000 Strips | 10-15% Savings |
| 50,000+ Strips | 15-25% Savings |
| Industry Indicator | Observation |
|---|---|
| Demand Growth | Stable to Growing |
| Export Demand | High |
| PCD Franchise Demand | Strong |
| Competition Level | High |
| Price Sensitivity | Moderate |
| Availability Across India | Excellent |
For pharma distributors, franchise companies, and exporters, Albendazole and Ivermectin Tablets remain a commercially viable product category due to their consistent demand and relatively stable pricing structure. While low-cost suppliers may appear attractive, buyers often prioritize manufacturers offering WHO-GMP compliance, reliable supply chains, quality assurance, and competitive commercial support. Companies such as BioCorp Lifesciences and other established manufacturers compete in this segment by providing a balance of quality, pricing, and business support for long-term partnerships.
Albendazole and Ivermectin Tablets continue to be an important product category within India’s pharmaceutical industry. Their consistent demand, wide therapeutic application, and export potential make them attractive for distributors, pharma franchise companies, and third-party manufacturing businesses.
Companies such as Delwis Healthcare, Biofield Pharma, Vibcare Pharma, BioCorp Lifesciences, Hiral Labs, Trumac Healthcare, Sarva Pharmaceuticals, and Fedley Healthcare are among the manufacturers operating in this segment. Businesses should compare quality standards, certifications, manufacturing capabilities, and commercial support before selecting a long-term manufacturing partner.
They are antiparasitic medicines commonly used for managing various parasitic worm infestations and related infections.
The most common strengths are Albendazole 400 mg + Ivermectin 6 mg and Albendazole 400 mg + Ivermectin 12 mg.
Yes, they are widely included in general medicine portfolios due to their consistent market demand.
Yes. Many pharmaceutical manufacturers in India offer private-label and contract manufacturing services.
WHO-GMP certification, ISO certification, regulatory compliance, and quality-control systems are key factors.
BioCorp Lifesciences operates in the pharmaceutical manufacturing and PCD pharma segment and supports pharma businesses through manufacturing solutions.
Manufacturers generally provide blister packs, Alu-Alu packs, and customized packaging options.
Yes. The formulation has demand across Africa, Asia, the Middle East, and several emerging pharmaceutical markets.
MOQ varies depending on the manufacturer, packaging requirements, and formulation specifications.
Compare manufacturers based on quality certifications, production capacity, pricing, packaging options, delivery timelines, and business support services.
